As more providers implement CCTA into their practices, doctors will have a clearer picture of their patients’ overall heart health in the early stages of CAD. This can set the stage for ...
Medical Device Network on MSN11d
FDA clears Caristo’s AI-powered CAD diagnostic softwareThe US Food and Drug Administration (FDA) has granted clearance to Caristo Diagnostics for CaRi-Plaque, an AI-assisted ...
Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...
Australia: A recent randomized clinical trial has highlighted the potential benefits of integrating coronary artery calcium ...
Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...
According to the Centers for Disease Control and Prevention, CAD is the leading cause of death ... uses coronary computed tomography angiography (CCTA) scans to measure FFR. Traditionally, doctors ...
Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease, today announced it has ...
The software quantifies coronary inflammation and arterial plaque build-up based on routine coronary computed tomography angiography (CCTA) scans. CAD was responsible for around 370,000 deaths ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback